Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range Thymosin Beta-4 2–5 mg TB-500 Frequency Twice weekly Administration Subcutaneous injection Cycle Length 8-12 weeks 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy

This comparison does not assign a generated winner or score.

  • Dose Range
  • Thymosin Beta-4
  • 2–5 mg
  • TB-500
  • Frequency
  • Twice weekly
  • Administration
  • Subcutaneous injection
  • Cycle Length
  • 8-12 weeks
  • 4-6 weeks
  • Onset Speed
  • Moderate (1-2 weeks)
  • Evidence Level
  • Moderate human trials (Phase 1-2)
  • Efficacy
More references

Related material